Financials of Ipca Laboratories Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Ipca Laboratories Ltd

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +1,5461,5121,5852,0342,0532,0332,0932,3552,2452,2472,3092,5562,392
Expenses +1,3301,3311,2781,6731,7221,7111,7001,9131,7821,8181,8922,0121,859
Operating Profit216181308361331322393441463429416545533
OPM %14%12%19%18%16%16%19%19%21%19%18%21%22%
Other Income +313645-191-118212620-17933-3038
Interest11183144332924231722192018
Depreciation67706990100989910098100100103108
Profit before tax16912925222528977290345368128331392446
Tax %32%37%34%39%23%96%31%29%25%49%29%28%18%
Net Profit +11078164136221119924627664233281364
EPS in Rs4.253.026.425.727.092.357.589.059.782.679.1911.1412.86

Financials of Ipca Laboratories Ltd

Profit & Loss

Annual income statement trend

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +3,2823,1442,8673,1563,2583,7464,6195,3955,7976,2047,6628,8979,505
Expenses +2,5392,6042,5732,7052,8033,0513,7153,8434,4725,2726,3387,1667,581
Operating Profit7435412944514556959041,5521,3259321,3241,7311,924
OPM %23%17%10%14%14%19%20%29%23%15%17%19%20%
Other Income +21322111415665595412317-114-139
Interest303235272822201211481418877
Depreciation103180163173178182210209232262357398411
Profit before tax6313611172622915467391,3891,1367458431,1311,296
Tax %24%28%18%26%18%19%18%17%20%34%37%30%
Net Profit +479254931952394426041,141890479523785941
EPS in Rs18.9610.073.697.719.4917.6023.9944.9434.8518.5821.5729.0835.86
Dividend Payout %13%5%0%6%5%9%10%9%11%22%19%14%

Financials of Ipca Laboratories Ltd

Balance Sheet

Capital structure and asset base

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital25252525252525252525252525
Reserves1,9342,1832,2342,4302,6633,0973,6024,6765,4395,8176,3076,9237,402
Borrowings +6039358677166284655012658071,4811,4381,3631,279
Other Liabilities +6486697657887999611,1301,0991,3491,3003,3263,4323,557
Total Liabilities3,2113,8123,8923,9604,1164,5495,2586,0667,6228,62311,09711,74412,263
Fixed Assets +1,3541,8002,0141,9831,9531,9402,0592,0722,4022,7514,5544,2674,371
CWIP165267129957366133235306140343622777
Investments91626136871203105059896268629801,203
Other Assets +1,6831,7291,7231,7462,0032,4222,7563,2543,9245,1055,3395,8755,912
Total Assets3,2113,8123,8923,9604,1164,5495,2586,0667,6228,62311,09711,74412,263

Financials of Ipca Laboratories Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +5224687092823415015701,0908568069451,321
Cash from Investing Activity +-369-689-218-149-135-165-509-521-851-725-1,215-870
Cash from Financing Activity +-136251-462-159-130-183-137-306427507-553-283
Net Cash Flow182929-2675153-76264432588-823169
Free Cash Flow144-207463147206322277731380347543551
CFO/OP88%100%251%74%88%88%80%86%80%110%94%97%

Financials of Ipca Laboratories Ltd

Ratios

Working capital efficiency and return ratios

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days504157586766715557588077
Inventory Days272293289290286316294337337276350336
Days Payable1109714513013715413514010183110111
Cash Conversion Cycle213237200218216228229251293251321302
Working Capital Days8268617480888810310271111101
ROCE %28%14%5%9%10%16%19%31%20%11%13%15%